For patients with poor clinical grade , those who received EGDT had a significantly lower rate of DCI ( 5 % versus 14 % ; P = 0.036 ) , modified Rankin Scale score of 0 to 3 at 3 months ( 52 % versus 36 % ; P = 0.026 ) , and shorter length of intensive care unit stay ( 14 versus 17 days ; P = 0.043 ) than those who received standard therapy .